InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
8
T+90 hit rate
57%
T+90 mean return
+3.3%
Across 23 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Francois Cedric, Chief Executive Officer. Director active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 34 filings have been logged. Split: 0 buy · 8 sells. Total volume traded: €2.3m. History available since 21 July 2021. The latest transaction was filed on 17 July 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations34 total
425,968 sharesCommon StockSEC:0001193125-26-224579:0
8,997 shares@ US$4.31Common StockSEC:0001127602-25-019413:0
65,203 shares@ US$4.31Common StockSEC:0001127602-25-019265:0
2,824 shares@ US$29.52361.8% of flowCommon StockSEC:0001127602-25-002375:0
13,551 shares@ US$30.42558.7% of flowCommon StockSEC:0001127602-25-001837:0
6,007 shares@ US$29.95823.8% of flowCommon StockSEC:0001127602-25-001620:0
130,662 shares0Common StockSEC:0001127602-25-001620:1
6,247 shares@ US$28.70213.9% of flowCommon StockSEC:0001127602-25-001197:0
182,146 shares0Common StockSEC:0000950170-24-120214:0
50,000 shares@ US$3.763.8% of flowCommon StockSEC:0001127602-24-008505:0
3,962 shares@ US$67.76695.5% of flowCommon StockSEC:0001127602-24-004718:0
2,843 shares@ US$64.13823.7% of flowCommon StockSEC:0001127602-24-002740:0
13,431 shares@ US$64.99617.7% of flowCommon StockSEC:0001127602-24-001970:0
72,094 shares0Common StockSEC:0001127602-24-001431:0
5,000 shares@ US$48.804.9% of flowCommon StockSEC:0000950170-23-065613:0
150,000 shares0Common StockSEC:0000950170-23-049003:0
300,000 shares@ US$2.6716.3% of flowCommon StockSEC:0001127602-23-023560:0
20,000 shares0Common StockSEC:0000950170-23-024276:0
30,000 shares@ US$2.671.6% of flowCommon StockSEC:0001127602-23-016189:0
382,946 shares0Common StockSEC:0000950170-23-015819:0
30,000 shares@ US$2.671.6% of flowCommon StockSEC:0001127602-23-013309:0
227,221 shares0Common StockSEC:0000899243-23-010771:0
30,000 shares@ US$2.671.6% of flowCommon StockSEC:0001127602-23-011206:0
100,000 shares@ US$3.767.8% of flowCommon StockSEC:0001127602-23-007876:0
13,908 shares0Common StockSEC:0000899243-23-005781:0
25 of 34 declarations
About Francois Cedric
Cedric Francois is the Chief Executive Officer of Apellis Pharmaceuticals, Inc. He leads the company's strategic operations and ensures the implementation of growth objectives. His industry experience enables him to make informed decisions that promote the long-term success of Apellis.
